scholarly article | Q13442814 |
P50 | author | Arja Häkkinen | Q40606601 |
P2093 | author name string | Tuulikki Sokka | |
Eswar Krishnan | |||
Pekka Hannonen | |||
Helen Hubert | |||
P2860 | cites work | Major public health benefits of physical activity | Q35063984 |
Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998:a longitudinal study of 3035 patients | Q38482066 | ||
Associations between demographic and disease-related variables and disability over the first five years of inflammatory polyarthritis: a longitudinal analysis using generalized estimating equations. | Q52072835 | ||
The effect of cigarette smoking on musculoskeletal-related disability | Q23909897 | ||
Smoking-gender interaction and risk for rheumatoid arthritis | Q24804476 | ||
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 | Q29614193 | ||
Aging, health risks, and cumulative disability | Q34463316 | ||
P433 | issue | 3 | |
P921 | main subject | disability | Q12131 |
questionnaire | Q747810 | ||
P304 | page(s) | 953-960 | |
P577 | publication date | 2004-03-01 | |
P1433 | published in | Arthritis & Rheumatology | Q4797636 |
P1476 | title | Normative values for the Health Assessment Questionnaire disability index: benchmarking disability in the general population | |
P478 | volume | 50 |
Q36675274 | A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors |
Q86846347 | A pilot randomized, placebo-controlled clinical trial to investigate the efficacy and safety of an extract of Artemisia annua administered over 12 weeks, for managing pain, stiffness, and functional limitation associated with osteoarthritis of the h |
Q36366162 | ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis |
Q48076353 | Acceptability of less than perfect health states in rheumatoid arthritis: the patients' perspective |
Q24241707 | Anakinra for rheumatoid arthritis |
Q24243387 | Anakinra for rheumatoid arthritis |
Q24657922 | Assessment of the age-specific disability weight of chronic schistosomiasis japonica |
Q99564907 | Association of age with the non-achievement of clinical and functional remission in rheumatoid arthritis |
Q34456168 | Associations between multiple accelerometry-assessed physical activity parameters and selected health outcomes in elderly people--results from the KORA-age study |
Q37224059 | Ataxia, dystonia and myoclonus in adult patients with Niemann-Pick type C. |
Q51180314 | Change of psychological distress and physical disability in patients with rheumatoid arthritis over the last two decades. |
Q38182440 | Comparative effectiveness of cycling of tumor necrosis factor-α (TNF-α) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-α inhibitor using a Bayesian approach |
Q51906908 | Cost of Finnish statutory inpatient rehabilitation and its impact on functional and work capacity of patients with early rheumatoid arthritis: experience from the FIN-RACo trial. |
Q48022172 | Course and prognostic factors of disability in community-dwelling older people with mild disability: the Rotterdam Study |
Q38860583 | Degenerative Spondylolisthesis is Related to Multiparity and Hysterectomies in Older Women |
Q33456162 | Development and assessment of floor and ceiling items for the PROMIS physical function item bank |
Q37329497 | Development and evaluation of a crosswalk between the SF-36 physical functioning scale and Health Assessment Questionnaire disability index in rheumatoid arthritis. |
Q89459292 | Development and prospective evaluation of CAPLET, a cancer ambulatory patient physical function longitudinal evaluation tool for routine clinical practice |
Q37089877 | Differences in presentation of younger and older systemic sclerosis patients in clinical trials |
Q48507695 | Different ethnic background is associated with distinct clinical profiles in the spondyloarthritides in the North and South of Brazil |
Q53506587 | Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms. |
Q34587206 | Distribution and determinants of functioning and disability in aged adults--results from the German KORA-Age study |
Q50155002 | Effect of treatment with biological agents for arthritis in Australia: the Australian Rheumatology Association Database |
Q91612432 | Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs |
Q37210207 | Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study |
Q36083931 | Establishing a Common Metric for Physical Function: Linking the HAQ-DI and SF-36 PF Subscale to PROMIS(®) Physical Function |
Q41685488 | Evaluation of functional capacity in individuals with signs and symptoms of musculoskeletal disease: results of the BRAZCO population study (Brazilian COPCORD Study). |
Q33577299 | Extending the floor and the ceiling for assessment of physical function |
Q41544298 | Functional limitations in the phase of clinically suspect arthralgia are as serious as in early clinical arthritis; a longitudinal study |
Q34361748 | Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study |
Q39173670 | Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study |
Q48151392 | Health status has improved more in women than in men with rheumatoid arthritis from 1994 to 2009: results from the Oslo rheumatoid arthritis register |
Q37075921 | Health status of individuals with serious mental illness |
Q37689724 | Health-related quality of life and functional ability in patients with early arthritis during remission steered treatment: results of the IMPROVED study |
Q59790838 | Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial |
Q51201512 | Increased incidence of herpes zoster among patients with systemic lupus erythematosus. |
Q44403988 | Influence of age and sex on functional outcome over time in a cohort of patients with recent-onset inflammatory polyarthritis: results from the Norfolk Arthritis Register. |
Q35106951 | Late-age onset systemic sclerosis. |
Q50114940 | Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies |
Q37172675 | Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria |
Q38010363 | Measures of adult general functional status: SF-36 Physical Functioning Subscale (PF-10), Health Assessment Questionnaire (HAQ), Modified Health Assessment Questionnaire (MHAQ), Katz Index of Independence in activities of daily living, Functional In |
Q38010372 | Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylos |
Q35636564 | Muscle strength, pain, and disease activity explain individual subdimensions of the Health Assessment Questionnaire disability index, especially in women with rheumatoid arthritis |
Q36001105 | Musculoskeletal Pain, Self-reported Physical Function, and Quality of Life in the Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) Cohort |
Q34205061 | Normative values for the Bath Ankylosing Spondylitis Functional Index in the general population compared with ankylosing spondylitis patients in Morocco. |
Q48372838 | Outcomes after rheumatoid arthritis patients complete their participation in a long-term observational study with tofacitinib combined with methotrexate: practical and ethical implications in vulnerable populations after tofacitinib discontinuation. |
Q35636868 | Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial |
Q41595008 | Patient's perspective of sustained remission in rheumatoid arthritis |
Q41704162 | Patient-reported outcomes of baricitinib in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment |
Q24798309 | Percentile benchmarks in patients with rheumatoid arthritis: Health Assessment Questionnaire as a quality indicator (QI) |
Q45111901 | Population-based normative values for the Western Ontario and McMaster (WOMAC) osteoarthritis index and the Australian/Canadian (AUSCAN) hand osteoarthritis index functional subscales |
Q44719067 | Predictors of Recovery After Conservative Treatment of AO-Type A Thoracolumbar Spine Fractures Without Neurological Deficit |
Q35743200 | Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosus |
Q36780940 | Quantitative measures to assess patients with rheumatic diseases: 2006 update |
Q40977464 | Sample Size Requirements for Traditional and Regression-Based Norms |
Q38848721 | Sarcopenia is associated with disability status-results from the KORA-Age study. |
Q35313168 | Scleroderma and evidence based non-pharmaceutical treatment modalities for digital ulcers: a systematic review |
Q35496180 | Self-reported disability in adults with severe obesity. |
Q42273153 | Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations |
Q37308290 | The PROMIS of better outcome assessment: responsiveness, floor and ceiling effects, and Internet administration |
Q37119095 | The impact of arthritis on the physical function of a rural Maya-Yucateco community and factors associated with its prevalence: a cross sectional, community-based study |
Q59411299 | The importance of disability as a health issue for mid-life women |
Q35163376 | The minimally important difference for the fatigue visual analog scale in patients with rheumatoid arthritis followed in an academic clinical practice |
Q61797049 | Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden-a phase III study of active psoriatic arthritis in patients with an inadequate response to conventional synthetic disease-modifying antirheumatic drugs |
Q39815843 | Treatment of rheumatoid arthritis (RA) in India-how and by whom: results from a speciality clinic-use of low-dose methotrexate (MTX) was inexplicably suboptimal. |
Q40235244 | Twenty-Year Outcome and Association Between Early Treatment and Mortality and Disability in an Inception Cohort of Patients With Rheumatoid Arthritis: Results From the Norfolk Arthritis Register. |
Q40676684 | Ultrasound-detected tenosynovitis independently associates with patient-reported flare in patients with rheumatoid arthritis in clinical remission: results from the observational study STARTER of the Italian Society for Rheumatology. |
Q91797957 | Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT |
Q47360442 | Validation and reliability of the Timed Up and Go test for measuring objective functional impairment in patients with long-standing rheumatoid arthritis: a cross-sectional study. |
Q34221999 | Valuation of scleroderma and psoriatic arthritis health states by the general public |
Q35842618 | Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters |
Q37207061 | Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study |
Search more.